New combo aims to control advanced breast cancer
Disease control
Recruiting now
This early-stage study tests the safety of combining two drugs—olaparib and estradiol—in postmenopausal women with advanced ER+/HER2- breast cancer that has spread or come back. The goal is to find the best dose and see if the combination can help control the disease. Only 6 part…
Phase: PHASE1 • Sponsor: Mary D Chamberlin • Aim: Disease control
Last updated May 26, 2026 09:40 UTC